Zealand Pharma sells insulin pump to Mannkind Corporation
On Tuesday, Zealand Pharma reports that a deal has been struck with US-based Mannkind Corporation entailing the sale of V-Go, an insulin pump. (Updated)
by christopher due karlsson, translated by daniel pedersen
Zealand Pharma, a biotech firm publicly listed in Denmark that has been undergoing comprehensive structural changes since March, announced on Tuesday that it has sold its insulin pump, dubbed V-Go, to US-based firm Mannkind Corporation.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Zealand Pharma rescue pen books USD 0.6m revenue in Q1
For subscribers
Zealand Pharma changes financing agreement
For subscribers
